Cryosite Limited is engaged in providing outsourced clinical trials depot services. The Company manages the entire clinical trial supply chain from importation, receipt, specialized ambient, cold, frozen, and liquid nitrogen storage for temperature-sensitive products, distribution and reverse logistics management. Its segments include Ambient, Cold, and Frozen, Ultra Frozen and Cryogenic and Cord blood. The Ambient, Cold, and Frozen segment storages and distributes small-molecule drugs and related products requiring ambient, refrigerated, or frozen conditions. Ultra Frozen and Cryogenic is engaged in specialized handling of materials requiring Ultra-Frozen or Cryogenic conditions, including Advanced Therapy Medicinal Products (ATMPs), such as Cell and Gene Therapies (CGT), cell therapies, and others. The cord blood segment is engaged in storage of cord blood cell and tissue samples for personal or directed therapeutic use, maintained under validated chain-of-identity controls.

• Revenue in AUD (TTM)14.12m
• Net income in AUD1.88m
• Incorporated1999
• Employees25.00

• Location
  Cryosite Ltd13a Ferndell St, South granvilleSYDNEY 2142AustraliaAUS
• Phone+61 28865-2000
• Fax+61 28865-2090
• Websitehttps://www.cryosite.com/